Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$55,823,144
-$78,372,690 QoQ
Shares Held
2,318,237
-51.5% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#165
of 2,837 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $6,692,750,905 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,477,275 | $1,771,888,099 | |
| 2 | JNJ |
Johnson & Johnson
|
5,024,318 | $1,276,026,041 | |
| 3 | ABBV |
AbbVie Inc.
|
4,805,342 | $1,209,216,259 | |
| 4 | AMGN |
Amgen Inc
|
2,239,516 | $810,973,532 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,152,239 | $650,933,874 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,052,294 | $463,973,179 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,503,750 | $450,231,874 | |
| 8 | PFE |
Pfizer Inc
This page
|
2,318,237 | $55,823,144 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,823,144 | 2,318,237 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $134,195,834 | 4,779,054 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $120,096,831 | 4,823,166 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $155,360,374 | 6,097,346 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $143,745,016 | 5,930,075 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $98,916,538 | 3,903,573 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $108,022,199 | 4,071,700 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $86,556,007 | 2,990,878 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $98,652,974 | 3,525,839 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $119,389,157 | 4,302,312 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $236,359,623 | 8,209,782 | Shares | Defined | 2024-01-10 | |
| 2023-09-30 | $263,680,171 | 7,949,357 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $306,821,267 | 8,364,811 | Shares | Defined | 2023-07-07 | |
| 2023-03-31 | $337,703,884 | 8,277,056 | Shares | Defined | 2023-04-19 | |
| 2022-12-31 | $423,668,665 | 8,268,319 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $490,610,644 | 11,211,395 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $639,644,950 | 12,199,980 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $662,798,471 | 12,802,752 | Shares | Defined | 2022-04-11 | |
| 2021-12-31 | $771,210,773 | 13,060,301 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $487,140,851 | 11,326,223 | Shares | Defined | 2021-11-01 | |
| 2021-06-30 | $445,359,395 | 11,372,814 | Shares | Defined | 2021-07-16 | |
| 2021-03-31 | $415,528,716 | 11,469,189 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $403,571,919 | 10,963,649 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $409,895,950 | 11,168,838 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $728,308,298 | 22,272,402 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $439,796,280 | 13,474,169 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||